Issued United States patents are listed below, grouped by technology. Foreign equivalents have been granted for many of these patents, but for simplicity and clarity are not listed here. Pending patent applications are likewise not listed here. Clicking on the title of the patent will take you to its entry at the USPTO.

Silver stain method:

• Morrissey JH. "Silver stains for proteins in gels--a modified procedure." U.S. Patent 4,468,466 (August 28, 1984)

Antibodies to human tissue factor:

• Edgington TS and Morrissey JH. "Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain." U.S. Patent 5,223,427 (June 29, 1993)
• Edgington TS and Morrissey JH. "Human tissue factor related DNA segments, polypeptides and antibodies." U.S. Patent 6,001,978 (December 14, 1999).

Novel Ca²⁺-dependent epitope tag/antibody combination for purifying recombinant proteins:

• Rezaie AR, Esmon CT, and Morrissey JH. "Expression and purification of recombinant soluble tissue factor." U.S. Patent 5,298,599 (March 29, 1994)

Use of recombinant soluble tissue factor (sTF) to treat bleeding:

• Morrissey JH and Comp PC. "Treatment of bleeding with modified tissue factor in combination with FVIIa." U.S. Patent 5,374,617 (December 20, 1994).
• Morrissey JH and Comp PC. "Treatment of bleeding with modified tissue factor in combination with an activator of FVIIa." U.S. Patent 5,504,064 (April 2, 1996).
• Morrissey JH and Comp PC. "Treatment of bleeding with modified tissue factor in combination with FVIIa." U.S. Patent 5,504,067 (April 2, 1996).

Assay for quantifying plasma levels of activated factor VII:

• Morrissey JH. "Quantitative clotting assay for activated factor VII." U.S. Patent 5,472,850 (December 5, 1995).
• Morrissey JH. "Quantitative clotting assay for activated factor VII." U.S. Patent 5,741,658 (April 21, 1998).
• Morrissey JH. "Quantitative clotting assay for activated factor VII." U.S. Patent 5,750,358 (May 12, 1998).

Taurolidine as an anti-neoplastic agent:

• Morrissey JH and Hamik A. "Use of taurolidine for treatment of leukemias." U.S. Patent 6,303,596 (October 16, 2001).

Improved thromboplastin reagents for performing prothrombin time (PT) clotting assays:

• Morrissey JH and Smith SA. "Thromboplastin reagents." U.S. Patent 7,148,067 (December 12, 2006).

Assay for quantifying plasma levels of factor VIIa-antithrombin complexes:

• Morrissey JH. "Assay for measuring factor VIIa-antithrombin complexes." U.S. Patent 7,494,782 (February 24, 2009).

Uses of tissue factor incorporated into nanoscale membrane bilayers (Nanodiscs):

• Morrissey JH, Pureza VS, and Sligar SG. "Tissue factor compositions and methods." U.S. Patent 7,622,437 (November 24, 2009).

Uses of polyphosphate to modulate the blood clotting system:

• Morrissey JH, Smith SA, Docampo R, and Mutch NJ. "Coagulation and fibrinolytic cascades modulator." U.S. Patent 7,682,808 (March 23, 2010).